Insights into neoadjuvant chemotherapy efficacy for stage 1B3 locally advanced cervical cancer: case series


  • Sumedha Gupta Department of Obstetrics and Gynaecology, VMMC and SJH, New Delhi, India
  • Ratika Gupta Department of Radiation Oncology, VMMC and SJH, New Delhi, India
  • Saritha Shamsunder Department of Obstetrics and Gynaecology, VMMC and SJH, New Delhi, India



Cervical cancer, NACT, Response, Surgery


Cervical cancer remains a leading cause of mortality among women worldwide, particularly in developing nations. While radical surgery is the established standard of care for early-stage disease, pelvic relapse post-surgery remains a concern. Neoadjuvant chemotherapy (NACT) preceding radical surgery has emerged as a promising approach, aiming to reduce tumor burden and improve surgical outcomes. We present three cases of stage 1B3 cervical cancer treated with three cycles of NACT repeated three weekly followed by radical hysterectomy. Post-operatively two patients received radiotherapy (External beam radiotherapy and brachytherapy) and one patient got lost to follow-up for 6 months and did not receive post-operative radiotherapy now under observation and regular follow-up. All the patients exhibited significant tumor reduction following chemotherapy, enabling successful surgical intervention. All patients remained in remission post-treatment. NACT showed effectiveness in reducing tumor size and facilitating successful radical surgery in patients with stage 1B3 cervical cancer. Our case series highlights the potential of NACT followed by radical surgery as a promising therapeutic strategy for stage 1B3 cervical cancer. NACT facilitated successful surgical intervention with favourable outcomes. Further research is warranted to elucidate the optimal patient selection criteria and the long-term benefits of this approach in improving survival rates and quality of life for cervical cancer patients.


Koh WJ, Greer BE and Abu-Rustum NR. Cervical cancer. J Natl Compr Canc Netw. 2013;11:320-43.

Lee DW, Lee KH, Lee JW, Park ST, Park JS, Lee HN, et al. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer? Int J Gynecol Cancer. 2013;23(7):1303-10.

Zhao H, He Y, Yang S, Qun Z, Yu-Mei W. Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis. Onco Targets Ther. 2019;12:1881-91.

Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri C, et al. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concomitant Chemotherapy and Radiotherapy in Patients with Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. J Clin Oncol. 2018;36(16):1548-55.

Li W, Zhang W, Sun L, Wang L, Cui Z, Zhao H, et al. Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer-A Propensity Score Matching Analysis. Front Oncol. 2021;11:730753.

Sardi JE, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, et al. Long-Term Follow-Up of the First Randomized Trial Using Neoadjuvant Chemotherapy in Stage Ib Squamous Carcinoma of the Cervix: The Final Results. Gynecol Oncol. 1997;67(1):61-9.

Cai HB, Chen HZ, Yin HH. Randomized Study of Preoperative Chemotherapy Versus Primary Surgery for Stage IB Cervical Cancer. J Obstet Gynaecol Res. 2006;32(3):315-23.

Chen H, Liang C, Zhang L, Huang S, Wu X. Clinical Efficacy of Modified Preoperative Neoadjuvant Chemotherapy in the Treatment of Locally Advanced (Stage IB2 to IIB) Cervical Cancer: Randomized Study. Gynecol Oncol. 2008;110(3):308-15.

Gadducci A, Sartori E, Maggino T, Zola P, Cosio S, Zizioli V, et al. Pathological Response on Surgical Samples is an Independent Prognostic Variable for Patients with Stage Ib2-IIb Cervical Cancer Treated with Neoadjuvant Chemotherapy and Radical Hysterectomy: An Italian Multicenter Retrospective Study (CTF Study). Gynecol Oncol. 2013;131(3):640-4.

Li R, Lu ST, Si JG, Liu B, Wang H, Mei YY, et al. Prognostic value of responsiveness of neoadjuvant chemotherapy before surgery for patients with stage IB(2)/IIA(2) cervical cancer. Gynecol Oncol. 2013;128(3):524-9.






Case Series